Archived version.
Learn more

PRICE INQUIRY nr SEMA/8/PR22389/2023 - being conducted as a market assessment study

19.07.2023

PRICE INQUIRY nr SEMA/8/PR22389/2023 - being conducted as a market assessment study

In connection with the implementation of the project titled “Design and development of an innovative solution - a generic drug belonging to the class of GLP-1 recept”, funded from the state budget by the Medical Research Agency, WZA Polfa Warszawa S.A., you are kindly requested to submit a bid for the purchase and delivery of the reference product Ozempic. Details of the price inquiry can be found in the documents attached below.

go back